HomeCompareGBERF vs JNJ

GBERF vs JNJ: Dividend Comparison 2026

GBERF yields 2.33% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $3.2K in total portfolio value· pulled ahead in Year 9
10 years
GBERF
GBERF
● Live price
2.33%
Share price
$679.49
Annual div
$15.85
5Y div CAGR
13.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.1K
Annual income
$1,084.44
Full GBERF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — GBERF vs JNJ

📍 JNJ pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGBERFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GBERF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GBERF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GBERF
Annual income on $10K today (after 15% tax)
$198.24/yr
After 10yr DRIP, annual income (after tax)
$921.77/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,064.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GBERF + JNJ for your $10,000?

GBERF: 50%JNJ: 50%
100% JNJ50/50100% GBERF
Portfolio after 10yr
$28.7K
Annual income
$2,886.92/yr
Blended yield
10.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GBERF
No analyst data
Altman Z
7.7
Piotroski
8/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GBERF buys
0
JNJ buys
0
No recent congressional trades found for GBERF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGBERFJNJ
Forward yield2.33%2.13%
Annual dividend / share$15.85$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR13.4%28%
Portfolio after 10y$27.1K$30.3K
Annual income after 10y$1,084.44$4,689.40
Total dividends collected$5.9K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GBERF vs JNJ ($10,000, DRIP)

YearGBERF PortfolioGBERF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,964$264.47$10,592$272.30+$372.00GBERF
2$12,039$307.32$11,289$357.73+$750.00GBERF
3$13,240$357.63$12,123$472.89+$1.1KGBERF
4$14,583$416.81$13,141$629.86+$1.4KGBERF
5$16,091$486.57$14,408$846.81+$1.7KGBERF
6$17,786$568.98$16,021$1,151.60+$1.8KGBERF
7$19,698$666.55$18,122$1,588.22+$1.6KGBERF
8$21,859$782.34$20,930$2,228.20+$929.00GBERF
9← crossover$24,309$920.10$24,792$3,191.91$483.00JNJ
10$27,095$1,084.44$30,274$4,689.40$3.2KJNJ

GBERF vs JNJ: Complete Analysis 2026

GBERFStock

Geberit AG develops, produces, and distributes sanitary products and systems for the residential and commercial construction industry in Switzerland and internationally. The company offers installation and flushing systems, such as installation technology and flushing systems for toilets, including cisterns and fittings; and piping systems consisting of building drainage and supply systems, as well as piping technology for use in buildings for drinking water, heating, gas, and other media. It also provides bathroom systems product comprising bathroom ceramics, furniture, showers, bathtubs, taps and controls, and shower toilets. The company sells its products under the Geberit brand name. It sells its products to wholesalers, plumbers, and sanitary engineers. Geberit AG was founded in 1874 and is headquartered in Rapperswil-Jona, Switzerland.

Full GBERF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this GBERF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GBERF vs SCHDGBERF vs JEPIGBERF vs OGBERF vs KOGBERF vs MAINGBERF vs ABBVGBERF vs MRKGBERF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.